Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 281, Issue 10, Pages 6546-6551Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M512635200
Keywords
-
Categories
Funding
- Medical Research Council [G0100729] Funding Source: Medline
- MRC [G0100729] Funding Source: UKRI
- Medical Research Council [G0100729] Funding Source: researchfish
Ask authors/readers for more resources
The local generation of active glucocorticoid by NADPH-dependent, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) oxoreductase activity, has emerged as an important factor in regulating hepatic glucose output and visceral adiposity. We have proposed that this NADPH is generated within the endoplasmic reticulum by the enzyme hexose-6-phosphate dehydrogenase. To address this hypothesis, we generated mice with a targeted inactivation of the H6PD gene. These mice were unable to convert 11-dehydrocorticosterone (11-DHC) to corticosterone but demonstrated increased corticosterone to 11-DHC conversion consistent with lack of 11 beta-HSD1 oxoreductase and a concomitant increase in dehydrogenase activity. This increased corticosterone clearance in the knock-out mice resulted in a reduction in circulating corticosterone levels. Our studies define the critical requirement of hexose-6-phosphate dehydrogenase for 11 beta-HSD1 oxoreductase activity and add a new dimension to the investigation of 11 beta-HSD1 as a therapeutic target in patients with the metabolic syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available